ClinicalTrials.govpublic full text
Association Between Galectin-3 Levels and Outcomes in Patients With Renal Cell Carcinoma, Transitional Cell Carcinoma , Non Small Cell Lung Cancer, and Hepatocellular Carcinoma, Treated With PD-1/PDL-1 Inhibitors
renal cell carcinoma (kidney cancer), non small cell lung cancer, hepatocellular carcinoma, transitional cell carcinoma
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 383548
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.